Back HCV Treatment

Grazoprevir/Elbasvir Hepatitis C Treatment Works Wells for People Who Inject Drugs

Merck's grazoprevir/elbasvir hepatitis C regimen was well-tolerated and cured more than 90% of injection drug users receiving opioid substitution therapy, according to results from the C-EDGE CO-STAR study published in the August 9 online edition of Annals of Internal Medicine. The investigators reported that adherence was good even though many study participants continued to use illicit drugs.


Read more: